The metabolomics services market size has grown rapidly in recent years. It will grow from $3.04 billion in 2025 to $3.49 billion in 2026 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to growth in life science research funding, expansion of pharmaceutical r&d pipelines, increased use of metabolomics in academic studies, availability of advanced analytical platforms, rising collaboration between research institutions.
The metabolomics services market size is expected to see rapid growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine research, rising demand for high-throughput metabolomics services, expansion of precision drug discovery programs, growing focus on systems biology approaches, increasing use of ai-driven data analytics. Major trends in the forecast period include increasing demand for outsourced metabolomics analysis, growing use of untargeted metabolomics services, expansion of biomarker discovery programs, rising integration of advanced bioinformatics tools, enhanced focus on drug development applications.
The rising demand for personalized medicine is anticipated to drive the growth of the metabolomics services market in the coming years. Personalized medicine is a healthcare approach that tailors medical decisions and treatments to individual patients based on their genetic profile, environmental influences, and lifestyle. This growing demand is fueled by advancements in genomic technologies, which allow for more precise and customized treatments, as well as an increasing focus on individualized patient care to achieve better outcomes. Metabolomics services support personalized medicine by delivering detailed metabolic profiles that enable treatments to be customized according to each patient’s unique biochemical state, resulting in more effective and targeted therapies. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based government organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Consequently, the rising demand for personalized medicine is driving the expansion of metabolomics services.
Major companies operating in the metabolomics services market are developing innovative diagnostic tools to improve disease detection and advance personalized medicine. Diagnostic tools refer to instruments and methods used to identify and evaluate medical conditions, diseases, or health issues, aiding healthcare professionals in making accurate diagnoses and guiding treatment strategies. For example, in October 2023, Sapient Bioanalytics LLC, a US-based biotechnology firm, introduced targeted metabolite and lipid panels for biomarker discovery and rapid time-to-insight. These panels provide a focused method for identifying and quantifying specific metabolites and lipids, enhancing the accuracy of biomarker detection. They are designed for quick time-to-insight, allowing fast turnaround of results, which is critical for timely decision-making in research and clinical contexts. Additionally, these panels incorporate advanced data analysis tools to interpret complex metabolic profiles and deliver actionable insights.
In June 2025, Bruker Corporation, a US-based scientific instruments and life sciences company, acquired Biocrates Life Sciences AG for an undisclosed sum. This acquisition enables Bruker to strengthen its multiomics strategy by integrating Biocrates’ mass spectrometry (MS)-based metabolomics kits, assays, software, and research services, thereby broadening its capabilities in quantitative metabolite and lipid analysis. Biocrates Life Sciences AG, an Austria-based manufacturer, offers standardized MS-based metabolomics solutions, including kits capable of measuring up to 1,881 biomarkers from a single sample, supporting laboratories worldwide in drug development, biomarker discovery, and precision healthcare.
Major companies operating in the metabolomics services market are Metabolon Inc., Biocrates Life Sciences AG, Nightingale Health, Human Metabolome Technologies Inc., MS-Omics, Creative Proteomics, Stemina Biomarker Discovery Inc., Metware Biotechnology Co. Ltd., OWL Metabolomics, BGI Metabolomics, MSDIAL Services, Chenomx Inc., BioMark Diagnostics, Microbiome Insights, Phenome Centre Birmingham, Australian National Phenome Centre, Biosfer Teslab, The Metabolomics Innovation Centre, One Way Liver Genomics, Revvity Omics Services.
North America was the largest region in the metabolomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metabolomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the metabolomics services market by increasing costs of imported mass spectrometers, chromatography systems, reagents, and data analysis software platforms. Research laboratories and pharmaceutical companies in North America and Europe are most affected due to reliance on advanced imported instrumentation, while Asia-Pacific faces cost pressure on service scalability. These tariffs are increasing service pricing and extending project timelines. At the same time, they are encouraging regional service providers to invest in local infrastructure, develop in-house analytical capabilities, and expand domestic metabolomics expertise.
The metabolomics services market research report is one of a series of new reports that provides metabolomics services market statistics, including metabolomics services industry global market size, regional shares, competitors with a metabolomics services market share, detailed metabolomics services market segments, market trends and opportunities, and any further data you may need to thrive in the metabolomics services industry. This metabolomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Metabolomics services encompass the analytical and technological methods employed to examine the metabolites present within a biological system. Metabolites are small molecules that result from cellular processes, and analyzing them provides a snapshot of an organism’s physiological state. These services are utilized to investigate disease mechanisms, discover biomarkers, and enhance drug development and personalized medicine.
The primary categories of metabolomics services are untargeted metabolomics services and targeted metabolomics services. Untargeted metabolomics services involve a broad analysis of all detectable metabolites in a biological sample without predetermined targets. The various offerings include metabolomics bioinformatics services, chromatography, mass spectrometry, and more, and they are utilized by a range of end-users such as agriculture and food, biomedical and pharmaceutical, academic and research laboratories, diagnostic laboratories, and others.
The metabolomics services market includes revenues earned by entities through metabolite identification, custom assay development, and metabolic profiling, and related nuclear magnetic resonance (NMR) spectroscopy systems, sample preparation kits, biomarker panels, and analytical platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The metabolomics services market size is expected to see rapid growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine research, rising demand for high-throughput metabolomics services, expansion of precision drug discovery programs, growing focus on systems biology approaches, increasing use of ai-driven data analytics. Major trends in the forecast period include increasing demand for outsourced metabolomics analysis, growing use of untargeted metabolomics services, expansion of biomarker discovery programs, rising integration of advanced bioinformatics tools, enhanced focus on drug development applications.
The rising demand for personalized medicine is anticipated to drive the growth of the metabolomics services market in the coming years. Personalized medicine is a healthcare approach that tailors medical decisions and treatments to individual patients based on their genetic profile, environmental influences, and lifestyle. This growing demand is fueled by advancements in genomic technologies, which allow for more precise and customized treatments, as well as an increasing focus on individualized patient care to achieve better outcomes. Metabolomics services support personalized medicine by delivering detailed metabolic profiles that enable treatments to be customized according to each patient’s unique biochemical state, resulting in more effective and targeted therapies. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based government organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Consequently, the rising demand for personalized medicine is driving the expansion of metabolomics services.
Major companies operating in the metabolomics services market are developing innovative diagnostic tools to improve disease detection and advance personalized medicine. Diagnostic tools refer to instruments and methods used to identify and evaluate medical conditions, diseases, or health issues, aiding healthcare professionals in making accurate diagnoses and guiding treatment strategies. For example, in October 2023, Sapient Bioanalytics LLC, a US-based biotechnology firm, introduced targeted metabolite and lipid panels for biomarker discovery and rapid time-to-insight. These panels provide a focused method for identifying and quantifying specific metabolites and lipids, enhancing the accuracy of biomarker detection. They are designed for quick time-to-insight, allowing fast turnaround of results, which is critical for timely decision-making in research and clinical contexts. Additionally, these panels incorporate advanced data analysis tools to interpret complex metabolic profiles and deliver actionable insights.
In June 2025, Bruker Corporation, a US-based scientific instruments and life sciences company, acquired Biocrates Life Sciences AG for an undisclosed sum. This acquisition enables Bruker to strengthen its multiomics strategy by integrating Biocrates’ mass spectrometry (MS)-based metabolomics kits, assays, software, and research services, thereby broadening its capabilities in quantitative metabolite and lipid analysis. Biocrates Life Sciences AG, an Austria-based manufacturer, offers standardized MS-based metabolomics solutions, including kits capable of measuring up to 1,881 biomarkers from a single sample, supporting laboratories worldwide in drug development, biomarker discovery, and precision healthcare.
Major companies operating in the metabolomics services market are Metabolon Inc., Biocrates Life Sciences AG, Nightingale Health, Human Metabolome Technologies Inc., MS-Omics, Creative Proteomics, Stemina Biomarker Discovery Inc., Metware Biotechnology Co. Ltd., OWL Metabolomics, BGI Metabolomics, MSDIAL Services, Chenomx Inc., BioMark Diagnostics, Microbiome Insights, Phenome Centre Birmingham, Australian National Phenome Centre, Biosfer Teslab, The Metabolomics Innovation Centre, One Way Liver Genomics, Revvity Omics Services.
North America was the largest region in the metabolomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metabolomics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the metabolomics services market by increasing costs of imported mass spectrometers, chromatography systems, reagents, and data analysis software platforms. Research laboratories and pharmaceutical companies in North America and Europe are most affected due to reliance on advanced imported instrumentation, while Asia-Pacific faces cost pressure on service scalability. These tariffs are increasing service pricing and extending project timelines. At the same time, they are encouraging regional service providers to invest in local infrastructure, develop in-house analytical capabilities, and expand domestic metabolomics expertise.
The metabolomics services market research report is one of a series of new reports that provides metabolomics services market statistics, including metabolomics services industry global market size, regional shares, competitors with a metabolomics services market share, detailed metabolomics services market segments, market trends and opportunities, and any further data you may need to thrive in the metabolomics services industry. This metabolomics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Metabolomics services encompass the analytical and technological methods employed to examine the metabolites present within a biological system. Metabolites are small molecules that result from cellular processes, and analyzing them provides a snapshot of an organism’s physiological state. These services are utilized to investigate disease mechanisms, discover biomarkers, and enhance drug development and personalized medicine.
The primary categories of metabolomics services are untargeted metabolomics services and targeted metabolomics services. Untargeted metabolomics services involve a broad analysis of all detectable metabolites in a biological sample without predetermined targets. The various offerings include metabolomics bioinformatics services, chromatography, mass spectrometry, and more, and they are utilized by a range of end-users such as agriculture and food, biomedical and pharmaceutical, academic and research laboratories, diagnostic laboratories, and others.
The metabolomics services market includes revenues earned by entities through metabolite identification, custom assay development, and metabolic profiling, and related nuclear magnetic resonance (NMR) spectroscopy systems, sample preparation kits, biomarker panels, and analytical platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Metabolomics Services Market Characteristics
3. Metabolomics Services Market Supply Chain Analysis
4. Global Metabolomics Services Market Trends and Strategies
5. Metabolomics Services Market Analysis of End Use Industries
7. Global Metabolomics Services Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Metabolomics Services Total Addressable Market (TAM) Analysis for the Market
9. Metabolomics Services Market Segmentation
10. Metabolomics Services Market Regional and Country Analysis
11. Asia-Pacific Metabolomics Services Market
12. China Metabolomics Services Market
13. India Metabolomics Services Market
14. Japan Metabolomics Services Market
15. Australia Metabolomics Services Market
16. Indonesia Metabolomics Services Market
17. South Korea Metabolomics Services Market
18. Taiwan Metabolomics Services Market
19. South East Asia Metabolomics Services Market
20. Western Europe Metabolomics Services Market
21. UK Metabolomics Services Market
22. Germany Metabolomics Services Market
23. France Metabolomics Services Market
24. Italy Metabolomics Services Market
25. Spain Metabolomics Services Market
26. Eastern Europe Metabolomics Services Market
27. Russia Metabolomics Services Market
28. North America Metabolomics Services Market
29. USA Metabolomics Services Market
30. Canada Metabolomics Services Market
31. South America Metabolomics Services Market
32. Brazil Metabolomics Services Market
33. Middle East Metabolomics Services Market
34. Africa Metabolomics Services Market
36. Metabolomics Services Market Competitive Landscape and Company Profiles
37. Metabolomics Services Market Other Major and Innovative Companies
40. Metabolomics Services Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Metabolomics Services Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses metabolomics services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for metabolomics services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metabolomics services market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Untargeted Metabolomics Services; Targeted Metabolomics Services2) By Analytical Platform And Services: Metabolomics Bioinformatics Services; Chromatography; Mass Spectrometry; Other Analytical Platform And Services
3) By End-User: Agriculture And Food; Biomedical And Pharmaceutical; Academic And Research Labs; Diagnostic Laboratories; Other End-Users
Subsegments:
1) By Untargeted Metabolomics Services: Metabolite Profiling; Comprehensive Metabolomic Analysis; High-Throughput Metabolomics; Non-Targeted Mass Spectrometry Analysis; Data Mining and Interpretation Services2) By Targeted Metabolomics Services: Quantitative Metabolite Analysis; Biomarker Discovery and Validation; Pathway Analysis; Specific Metabolite Measurement; Targeted Mass Spectrometry Services
Companies Mentioned: Metabolon Inc.; Biocrates Life Sciences AG; Nightingale Health; Human Metabolome Technologies Inc.; MS-Omics; Creative Proteomics; Stemina Biomarker Discovery Inc.; Metware Biotechnology Co. Ltd.; OWL Metabolomics; BGI Metabolomics; MSDIAL Services; Chenomx Inc.; BioMark Diagnostics; Microbiome Insights; Phenome Centre Birmingham; Australian National Phenome Centre; Biosfer Teslab; The Metabolomics Innovation Centre; One Way Liver Genomics; Revvity Omics Services
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Metabolomics Services market report include:- Metabolon Inc.
- Biocrates Life Sciences AG
- Nightingale Health
- Human Metabolome Technologies Inc.
- MS-Omics
- Creative Proteomics
- Stemina Biomarker Discovery Inc.
- Metware Biotechnology Co. Ltd.
- OWL Metabolomics
- BGI Metabolomics
- MSDIAL Services
- Chenomx Inc.
- BioMark Diagnostics
- Microbiome Insights
- Phenome Centre Birmingham
- Australian National Phenome Centre
- Biosfer Teslab
- The Metabolomics Innovation Centre
- One Way Liver Genomics
- Revvity Omics Services
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.49 Billion |
| Forecasted Market Value ( USD | $ 5.97 Billion |
| Compound Annual Growth Rate | 14.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
